Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.

Name: Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.
License: Public Domain

Meyer Children's Hospital IRCCS

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

cystic fibrosis (cf)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 444894
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.